Blog
Trinity: Deep Dive
The AI Context Layer: The Missing Link in AI-Ready Data
Trinity: Deep Dive A closer look at what powers commercialization decisions in life sciences Most commercial life sciences organizations have invested heavily in data. They have lakehouses, harmonized data feeds, and dashboard environments such as Power BI, Tableau, and Snowflake that their teams rely on every day. These tools already carry semantic models: metric definitions,…
Filter posts by:
Trinity: Deep Dive
The AI Context Layer: The Missing Link in AI-Ready Data
Trinity: Deep Dive A closer look at what powers commercialization decisions in life sciences Most commercial life sciences organizations have invested heavily in data. They have lakehouses, harmonized data feeds, and dashboard environments such as Power BI, Tableau, and Snowflake that...
Trinity: Deep Dive
De-Risk Market Access: Simulate Payer Decisions Before You Go to Market
Trinity: Deep Dive A closer look at what powers commercialization decisions in life sciences Testing payer strategy can be expensive Market access teams routinely make high-stakes decisions with incomplete information and compressed timelines. Primary market research remains the gold standard, but...
Market Access Trends 2026
How China’s Layered Access System and Real-World Evidence Are Changing Market Access
China is evolving beyond a single public reimbursement model toward a layered access system that combines national coverage, commercial funding, and early access programs. In 2025, these changes began to reshape how manufacturers think about pricing, evidence, and launch sequencing. In...
Market Access Trends 2026
How Four Pillars Are Latin America and MENA Market Access
Latin American and MENA markets have long faced the challenge of balancing constrained public budgets with rising demand for newer therapies. In 2025, governments in these regions took concrete steps to modernize pricing rules, raise evidence expectations, expand partnership models, and...
Market Access Trends 2026
How Regulatory–HTA Convergence Is Reshaping European Market Access
Across Europe, 2025 accelerated a shift from sequential regulatory and access steps to more connected process through the Joint Clinical Assessment. Regulatory approvals, and clinical portion of HTA evaluation are now more tightly linked, which has the potential to bring the...
Market Access Trends 2026
How MFN and Direct-to-Consumer Models Are Rewiring US Market Access
Globally, 2025 marked a shift from debating drug pricing policy to implementing it. Pricing pressure intensified, evidence expectations rose, and long-standing access models began to change amid political and fiscal realities. In Trinity’s webinar “Around the World in Market Access 2026:...
